Related references
Note: Only part of the references are listed.Inflammatory cytokines in major depressive disorder: A case-control study
Paolo Cassano et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2017)
Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies
C. A. Kohler et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets
Ji-chun Zhang et al.
CURRENT NEUROPHARMACOLOGY (2016)
Val66Met BDNF polymorphism as a vulnerability factor for inflammation-associated depressive symptoms in women with breast cancer
Larissa N. Dooley et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Agmatine ameliorates lipopolysaccharide induced depressive-like behaviour in mice by targeting the underlying inflammatory and oxido-nitrosative mediators
Nitin B. Gawali et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2016)
Esculetin attenuates lipopolysaccharide (LPS)-induced neuroinflammatory processes and depressive-like behavior in mice
Lingpeng Zhu et al.
PHYSIOLOGY & BEHAVIOR (2016)
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Andrew H. Miller et al.
NATURE REVIEWS IMMUNOLOGY (2016)
TNF-alpha inhibition prevents cognitive decline and maintains hippocampal BDNF levels in the unpredictable chronic mild stress rat model of depression
Tugce Demirtas Sahin et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder
Rita Haapakoski et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Resveratrol abrogates lipopolysaccharide-induced depressive-like behavior, neuroinflammatory response, and CREB/BDNF signaling in mice
Li Ge et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Antidepressant Effects of TrkB Ligands on Depression-Like Behavior and Dendritic Changes in Mice After Inflammation
Ji-chun Zhang et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
The Met allele of BDNF Val66Met polymorphism is associated with increased BDNF levels in generalized anxiety disorder
Fernanda P. Moreira et al.
PSYCHIATRIC GENETICS (2015)
Association Between Smoking, Nicotine Dependence, and BDNF Val66Met Polymorphism with BDNF Concentrations in Serum
Mumtaz Jamal et al.
NICOTINE & TOBACCO RESEARCH (2015)
Val66Met polymorphism and serum brain-derived neurotrophic factor in bipolar disorder: an open-label trial
I. Grande et al.
ACTA PSYCHIATRICA SCANDINAVICA (2014)
Interaction between stress and the BDNF Val66Met polymorphism in depression: a systematic review and meta-analysis
Georgina M. Hosang et al.
BMC MEDICINE (2014)
Association between serum brain-derived neurotrophic factor and plasma interleukin-6 in major depressive disorder with melancholic features
Konstantinos Patas et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484)
M. L. Molendijk et al.
MOLECULAR PSYCHIATRY (2014)
ETAZOLATE ABROGATES THE LIPOPOLYSACCHARIDE (LPS)-INDUCED DOWNREGULATION OF THE cAMP/pCREB/BDNF SIGNALING, NEUROINFLAMMATORY RESPONSE AND DEPRESSIVE-LIKE BEHAVIOR IN MICE
J. Guo et al.
NEUROSCIENCE (2014)
Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity
Francesca Calabrese et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
The role of brain-derived neurotrophic factor in comorbid depression: possible linkage with steroid hormones, cytokines, and nutrition
Tadahiro Numakawa et al.
FRONTIERS IN PSYCHIATRY (2014)
Biological differences between melancholic and nonmelancholic depression subtyped by the CORE measure
Lucas Spanemberg et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2014)
Poly I:C-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression
Sinead M. Gibney et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a Pilot and Replication Study
G. I. Papakostas et al.
MOLECULAR PSYCHIATRY (2013)
Brain-Derived Neurotrophic Factor Serum Levels and Genotype: Association with Depression during Interferon-α Treatment
Francis E. Lotrich et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Are variations in whole blood BDNF level associated with the BDNF Val66Met polymorphism in patients with first episode depression?
Maj Vinberg et al.
PSYCHIATRY RESEARCH (2013)
Genetics of serum BDNF: Meta-analysis of the Val66Met and genome-wide association study
Antonio Terracciano et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2013)
Interplay between pro-inflammatory cytokines and growth factors in depressive illnesses
Marie-Claude Audet et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression
Yang Liu et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
Increase in Serum Brain-Derived Neurotrophic Factor in Met Allele Carriers of the BDNF Val66Met Polymorphism Is Specific to Males
Boudewijn A. A. Bus et al.
NEUROPSYCHOBIOLOGY (2012)
Synaptic Dysfunction in Depression: Potential Therapeutic Targets
Ronald S. Duman et al.
SCIENCE (2012)
Inflammatory Factors Contribute to Depression and Its Comorbid Conditions
Hymie Anisman et al.
SCIENCE SIGNALING (2012)
Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders
Anita E. Autry et al.
PHARMACOLOGICAL REVIEWS (2012)
Neurotrophins Role in Depression Neurobiology: A Review of Basic and Clinical Evidence
Fani L. Neto et al.
Current Neuropharmacology (2011)
Depressive symptoms following interferon-α therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor?
Gunter Kenis et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment
M. L. Molendijk et al.
MOLECULAR PSYCHIATRY (2011)
The impact of childhood abuse and recent stress on serum brain-derived neurotrophic factor and the moderating role of BDNF Val66Met
Bernet M. Elzinga et al.
PSYCHOPHARMACOLOGY (2011)
Meta-Analysis of Brain-Derived Neurotrophic Factor p.Va166Met in Adult ADHD in Four European Populations
C. Sanchez-Mora et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2010)
A Meta-Analysis of Cytokines in Major Depression
Yekta Dowlati et al.
BIOLOGICAL PSYCHIATRY (2010)
The effect of depression, BDNF gene val66met polymorphism and gender on serum BDNF levels
Erol Ozan et al.
BRAIN RESEARCH BULLETIN (2010)
Genetic association of the interaction between the BDNF and GSK3B genes and major depressive disorder in a Chinese population
Kerang Zhang et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity
M. Verhagen et al.
MOLECULAR PSYCHIATRY (2010)
Ethnic Differences in Brain-derived Neurotrophic Factor Val66Met Polymorphism in Croatian and Korean Healthy Participants
Nela Pivac et al.
CROATIAN MEDICAL JOURNAL (2009)
The Met allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations
U. E. Lang et al.
MOLECULAR PSYCHIATRY (2009)
Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression
Reiji Yoshimura et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Serum brain-derived neurotrophic factor, depression, and antidepressant medications: Meta-analyses and implications
Srijan Sen et al.
BIOLOGICAL PSYCHIATRY (2008)
Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine
Francesco Matrisciano et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
Is it time to reassess the BDNF hypothesis of depression?
J. O. Groves
MOLECULAR PSYCHIATRY (2007)
The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans
Luciana Ribeiro et al.
NEUROREPORT (2007)
No association between the BDNF Val66Met polymorphism and mood status in a non-clinical community sample of 7389 older adults
Paul G. Surtees et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2007)
Val66met polymorphism and serum brain-derived neurotrophic factor levels in bipolar disorder
J. Tramontina et al.
MOLECULAR PSYCHIATRY (2007)
Peripheral immune activation by lipopolysaccharide decreases neurotrophins in the cortex and hippocampus in rats
ZW Guan et al.
BRAIN BEHAVIOR AND IMMUNITY (2006)
Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression
J Schumacher et al.
BIOLOGICAL PSYCHIATRY (2005)
The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function
MF Egan et al.
CELL (2003)
Color and genomic ancestry in Brazilians
FC Parra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Antidepressants and neuroplasticity
C D'Sa et al.
BIPOLAR DISORDERS (2002)
dbSNP: the NCBI database of genetic variation
ST Sherry et al.
NUCLEIC ACIDS RESEARCH (2001)
Neuronal plasticity and survival in mood disorders
RS Duman et al.
BIOLOGICAL PSYCHIATRY (2000)
Share Paper
